Final sign-on letter to Abbott re: access to heat-stable LPV/r

[Guest guest]

Apologies for cross-posting.

Below please find a final list of signatures for the letter to Abbott

Laboratories. More information and a formatted copy of this letter

including footnotes can be found at www.doctorswithoutborders.org.

Sincerely,

Kate

Kate

U.S. Coordinator, Campaign for Access to Essential Medicines

Doctors Without Borders/Médecins Sans Frontières (MSF)

333 Seventh Avenue, 2nd Floor * New York, NY * 10001-5004 * USA

Tel: +1-212-655-3762

Cell: +917-331-9077

Fax: +1-212-679-7016

E-mail: kate.evans@...

April 5, 2006

Miles White

Chairman and CEO

Abbott Laboratories

100 Abbott Park Road

Abbott Park, IL 60064

Dear Mr. White,

We are writing to you to express our concern about the lack of availability

in developing countries of the new melt extrusion (Meltrex) formulation of

lopinavir/ritonavir (LPV/r), marketed as Kaletra (200/50mg tablets).

LPV/r has been recognized as an essential medicine by the WHO and will be

included in its revised antiretroviral treatment guidelines, in which

boosted protease inhibitors represent the cornerstone of second-line

therapy. As you know, the tablet formulation of LPV/r, approved by the US

Food and Drug Administration in October 2005, has critically important

advantages for patients in developing countries: no dietary restrictions,

lower pill burden, and most importantly, storage without refrigeration.

Due to the storage requirements of the old formulation, there is the risk

that some patients in tropical climates are currently using degraded LPV/r

capsules. In short, there is an urgent need in developing countries for

access to the new heat-stable formulation of LPV/r, as no other boosted

protease inhibitors are practical to use in the hot climates of many of

these countries.

We urge Abbott to take the following actions to make this crucial

second-line option accessible in developing countries:

1. Immediately file for registration of the new LPV/r formulation in all

countries where the old formulation was registered or pending, as well as

in other developing countries.

According to the WHO/AMDS registration database published in October 2005,

the old formulation of LPV/r (133/33.3 mg soft gel capsules) is registered

in 55 countries and registration is pending in 13 others, covering 68 of

the 69 countries eligible in Abbott’s Access Program. But the new

formulation of the drug has not been registered in any country except for

the US. We urge you to immediately file for registration of the new

formulation of LPV/r (200/50mg tablets) in developing countries, so that

the old formulation can be replaced by the new one, as was done in the US.

2. Communicate the countries and the filing dates where registration of

the new formulation of LPV/r is pending and a timeline for submissions to

remaining countries.

We ask that Abbott communicate the countries and the filing dates where

registration of the new formulation of LPV/r is pending so that health

advocates in these countries can work with national drug regulatory

authorities to overcome any delays and provide a timeline for submitting

remaining registration requests.

3. Publish a price for the new formulation of LPV/r for least-developed

and middle-income countries.

Since May 2002, Abbott has been selling the old formulation of LPV/r in

Africa and Least Developed Countries for $500 per patient per year on an

FOB basis (freight, insurance, customs handling, taxes and duties paid by

purchaser). Abbott has not yet made public any price for the new

formulation of LPV/r in developing countries. We ask that Abbott establish

a price that is at least as low as the price for the old formulation in

least-developed countries.

Abbott’s Access Program for the old formulation of LPV/r excludes

middle-income countries, resulting in prices up to 12 times more than in

least-developed African countries. We urge you to make the new formulation

available at an affordable price in middle-income countries where millions

live on less than US $2 per day.

4. Develop a heat-stable formulation of RTV and make it accessible in

developing countries.

A separate, heat-stable formulation of ritonavir (RTV), marketed as Norvir,

is also needed in developing countries so that care-providers can implement

the forthcoming WHO guidelines and pair RTV with other available and

affordable, heat-stable protease-inhibitors.

5. Develop a pediatric formulation of the new formulation of LPV/r.

WHO draft pediatric guidelines recommend LPV/r for use in children if there

is cold-chain access. While this new formulation overcomes the storage

challenges presented by the old formulation, care-providers would not be

able to cut or crush tablets because the new LPV/r is a coated tablet.

Therefore, care-providers need a pediatric version of this formulation so

that they can provide adequate second-line regimens for children as well as

adults.

6. Work with countries to make the new formulation of LPV/r easily

available while registration applications are being considered.

Because the drug registration process can take months if not years to

complete, we ask that Abbott establish a reliable interim system to

distribute this new formulation to treatment programs in developing

countries while registration is pending.

Sincerely,

INTERNATIONAL

, United Nations Secretary General’s Special Envoy for

HIV/AIDS in Africa

Craig McClure, Executive Director, The International AIDS Society

Bianca Kamps, Director, International Dispensary Association (IDA) -

HIV/AIDS Group

Médecins Sans Frontières / Doctors Without Borders (MSF)

European AIDS Treatment Group

UNITED STATES

American Academy of HIV Medicine (AAHIVM)

AIDS Treatment Activist Coalition (ATAC)

The Drug Development Committee of AIDS Treatment Activist Coalition (ATAC)

Elaine J. Abrams, MD, Professor of Pediatrics & Epidemiology, Director,

MTCT-Plus, International Center of AIDS Care and Treatment Programs

Mailman School of Public Health, Columbia University

Hirschhorn MD MPH, Associate Director, Office of International

Programs,

Harvard Medical School Division of AIDS

Joia S. Mukherjee, MD, MPH, Medical Director, Partners In Health

Hoos, MD, MPH , Director Multicountry Antiretroviral Program (MCAP)

Mailman School of Public Health, Columbia University

Wafaa El-Sadr, MD, MPH, Columbia University

Mark Mirochnick, MD, Associate Professor of Pediatrics, Boston University

School of Medicine

Ruby Faysey, MD, MPH, Pediatric Clinical Advisor, ICAP, Columbia University

School of Public Health

Ruth Kuhn, SC, Coordinator Region VI Coalition for Responsible Investment

Sisters of Charity of Cincinnati, Corporate Responsibility Committee

Compere, Chair, Interfaith Center on Corporate Responsibility,

HIV/AIDS Caucus

Chief Administrative Officer/Director of Shareholder Advocacy, Boston

Common Asset Management

Sister Dolores Bourquin HM, Sisters of the Humility of

Rowan, Corporate Responsibility Coordinator, knoll Sisters

len Sbrissa, CSJ, Office of Peace, Justice and Integrity of Creation,

Sisters of St. ph of La Grange, IL

Scondras, President, Search for a Cure

Outterson, Associate Professor of Law, West Virginia University

Foundation for Integrative AIDS Research (FIAR)

Gay Men’s Health Crisis (GMHC)

Global AIDS Alliance (GAA)

The Center for AIDS Information & Advocacy

Treatment Action Group (TAG)

Student Global AIDS Campaign

Health Global Access Project (GAP)

Health & Development Networks

National Jesuit Committee on Investment Responsibility (NJCIR)

Universities Allied for Essential Medicines – US and Canada

Dominican Sisters of Hope

Mercy Investment Program

Sisters of Mercy Regional Community of Detroit

Ursuline Sisters of Tildonk-U.S. Province

ARGENTINA

Nexo Salud

Iglesia Evangelica Luterana Unida en Argentina y Uruguay, Pasotral

Ecumenica, VIH-SIDA,

Coordinador Regional Plan de Accion en VIH-SIDA de la Federacion

Luterana Mundial

AUSTRALIA

Professor Ziegler, MB BS, MD, FRACP, FAAAAI Head, HIV Service, Sydney

Children’s Hospital, NSW

Professor Doherty, Head of Department of Paediatrics, Monash

University, and Head of Paediatric Infectious Diseases, Southern Health,

VIC

Assistant Professor Price, Snt Lecturer HIV Immunology, University

of Western Australia, WA

Professor Martyn A French, MB ChB, MD, FRCPath, FRCP, FRACP, Royal Perth

Hospital and University of Western Australia, WA

Haill, President, The Australian AIDS Fund Incorporated, VIC

Dr. Bradford AM, Sexual Health, Cairns, QLD

Dr. , MBBS, DipSHM, FRACP, FAChSHM, Chair of Education,

Australasian Chapter of Sexual Health Medicine

Dr. N. Goldwater, BSc, MBBS, FRACP, FRCPA, MASM, Microbiology &

Infectious Diseases Department, Women and Children’s Hospital, Adelaide, SA

Dr. Margaret Gibbons, MBBS, MTH, General Practitioner, Tobwabba Aboriginal

Medical Service, NSW

Dr. Mark W. , BSc, MBBS, PhD, FRACP, Infectious Disease Physician

Dr. Deborah Couldwell, MBBS, MM, FAChSHM, Staff Specialist Sexual Health

Medicine, Parramatta Sexual Health Clinic, NSW

Dr. Post, Infectious Diseases Physician, The Prince of Wales

Hospital NSW

Dr. Marisa Gilles, KPHU Broome, WA

Mark Bebbington, Policy and International Manager, Australian Federation of

AIDS Organisations, Inc. Newtown, NSW

L. Dorgogna, Clinical Immunology and Biochemical Genetics, Royal Perth

Hospital, WA

Blyth CNC, n HIV Consultancy, The Alfred, Melbourne, VIC

Pam Price, HIV Women’s Health Statewide, Adelaide, SA

Chambers, STD Services, Royal Adelaide Hospital, SA

, Harm Minimisation Coordinator, We Help Ourselves (WHOS),

Redfern, NSW

Mark , Senior Medical Officer, AIDS Medical Unit, Brisbane, QLD

Mark Beltchev, Nurse Manager, HIV Unit, The Alfred, Melbourne, VIC

AUSTRIA

Gottfried Mernyi, Managing Director, Protestant Association for World

Mission

Sonja Hauser, Assoc. AIDS Life, Production

Anton Mair, Head of Dept. for Evaluation, Development Policy and

Strategies, Federal Ministry of Foreign Affairs

Birgit Habermann, Coordinating Committee for Development Issues (KEF) at

the Academy of Sciences

Dr. Florian Breitenecker, General Practioner, Detention Centre fstadt

Stephan Neuhäuser, International Research ation, Federal Ministry for

Education, Science and Culture

Dr. Norbert Kohrgruber (MD), Medical University of Vienna,

Dr. Öllinger, Dermatologist/Spezialist HIV/Aids, General Hospital

Linz (AKH)

Dr. Harald Schopper, Head of the Detention Centre fstadt

Univ. Prof. Dr. Christoph Wenisch, President of the Austrian Society of

Infectious Diseases, Kaiser Franz f Hospital

Dr. N. Vetter, Head of the Lung Dept. Otto-Wagner Hospital

Dr. Steuer, Otto-Wagner Hospital

Dr. Brigitte Schmied, Otto-Wagner Hospital

Dr. Wolfgang Steflitsch, Otto-Wagner Hospital

Dr. Heinrich Haber, Otto-Wagner Hospital

Dr. Manfred Gartner, Otto-Wagner Hospital

Dr. Gunvor Koitz, Otto-Wagner Hospital

Dr. Herbert Keller, Otto-Wagner Hospital

Dr. Wolfgang Scholz, Otto-Wagner Hospital

Dr. Aichelburg, Otto-Wagner Hospital

Dr. Geit, General Hospital Linz

Dr. Armin Reiger, Head of HIV/AIDS Department, General Hospital Vienna

(AKH)

Göd, Chairwoman, Association ONGHALO – Future for Africa

Jakob Krisper, Vice Chairman, Association ONGHALO – Future for Africa

Markus Fux, Board Member, Association ONGHALO – Future for Africa

Bernhard Hlawati, Board Member, Association ONGHALO – Future for Africa

BELGIUM

Dirk Pyck, Directeur, Sensoa (Dutch speaking platform of AIDS NGOs)

Professor Colebunders, Medical Tropical Institute, Antwerpen

Mr. Thierry , Director, Prevention SIDA

BRAZIL

GESTOS - Soropositividade, Comunicação e Gênero

ABIA - Associação Brasileira Interdisciplinar de AIDS

CONECTAS Direitos Humanos

Grupo Pela Vidda São o

DAWN Brasil

GAPA/São o

GAPA/ RS

LACCASO - Consejo Latinoamericano y del Caribe de ONGs con Servicio en

VIH/SIDA

GIV – Grupo de Inventivo à Vida

CAMBODIA

Dr. Juian Elliot MD, Technical Advisor for HIV Treatment and Care, Phnom

Penh

Dr. Huffam, Technical Advisor for HIV Treatment and Care, Phnom Penh

CANADA

Canadian HIV/AIDS Legal Network

Canadian AIDS Society

Interagency Coalition on AIDS and Development (ICAD)

Canadian Harm Reduction Network

Oxfam Canada

Dignitas International

Canadian Crossroads International

RESULTS Canada

Dr. Noah Novogrodsky

Dr. Lexchin, Associate Professor, School of Health Policy and

Management, York University

Dr. Jill Cohen

Bonnie Gray, Canadian Support of Rural African Initiatives (CSRAI)

CHINA

Yiming Shao, M.D., Ph.D., Chief Expert on AIDS, Chinese Center for Disease

Control and Prevention (China CDC), National Center for AIDS/STD Control

and Prevention (NCAIDS), China CDC, Director, Division of Research on

Virology and Immunology, NCAIDS, Chairman, Committee on Virology, Chinese

Society for Microbiology

Odilon Couzin, Executive Director, China AIDS Info

DENMARK

Nina Friss-Moleer, MD, PhD, Clinical Research Associate, Copenhagen HIV

Programme, Hvidovre University Hospital

Sören Thybo, MD, MSc, Consultant, Department of Infectious Diseases,

Rigshospitalet

ECUADOR

Darío Abarca, Ecuadorian Coalition of PLWHA

EL SLAVADOR

Asociación Atlacat

FRANCE

Pr. Delaporte, UMR 145 L'Institut de recherche pour le developpement

(IRD)/ Université de Montpellier

Pr. t Mandelbrot, Hôpital Louis Mourier

Pr. Jean-Michel Molina, Chef de Service, Maladies Infectieuses, Hôpital

Saint Louis

Dr. Suna Balkan, Service de Maladies Infectieuses, Hôpital Saint Louis

Dr. Jean-Baptiste Guiard Schmidt, Service des Maladies Infectieuses et

Tropicales, Hôpital Tenon

Pr. Yeni, Chef de Service, Maladies Infectieuses, Hôpital Bichat

Dr. François Bourdillon, Président de la Société de Santé Publique

Pr. François Dabis, Unité INSERM 593, Institut de Santé Publique,

Epidémiologie et Développement (ISPED)

Dr. Xavier Anglare, ISPED

Dr. Seyler, ISPED

Dr. Danel, ISPED

Dr. Besigin Tonwe-Gold, ISPED

Dr. Valériane Leroy, ISPED

Dr. Elise Klement, Service de Maladies Infectieuses, Hôpital

Pitié-Salpêtrière

Dr. Veraspuech, Bordeaux

Fleutelot, Head of International Programs, Sidaction,

TRT-5

Act Up-Paris

Act Up-Toulouse

GERMANY

Albert sen, Chair of the Ecumenical Pharmaceutical Network Nairobi

Dr. med Günther Schmutz, Arzt für Innere Medizin, Haematologie und

Internistische Onkologie, HIV-Schwerpunktpraxis

Dr. med. Stefan Esser, Leiter der HIV-Ambulanz am Universitatsklinikum

Essen, Klinik für Dermatologie und Venerologie

Bernd Pastors, Managing Director and Member of the Board, German Medical

Organization, Action Medeor

Prof. Dr. Schlomor Staszewski, HIVCENTER, Klinikum der Johann Wolfgang

Goethe- Universität furt am Main Medizinische Klinik III

Dr. med. Tessa Lennemann, HIVCENTER Klinikum der Johann Wolfgang Goethe-

Universität furt am Main Medizinische Klinik III

Dr. med. Heiko n, HIV-Schwerpunktpraxis

Dr. med. Heribert Knechten, 1. Vorstandsvorsitzender, Deutsche

Arbeitsgemeinschaft niedergelassener Ärzte in der Versorgung

HIV-Infizierter e.V. (DAGNÄ e.V.)

Dr. med. Hartmann, Arzt, Praxis mit HIV Schwerunkt

Netzwerk der Therapieaktivisten, c/o Projekt Information e.V.

Dr. Escobar Pinzón, Bundesgeschäftsführer, Deutsche AIDS-Hilfe

e.V

Dr. med. Albrecht Ulmer, Gemeinschaftspraxis

Dr. med. s Carganico, Facharzt für Allgemeinmedizin,

Gemeinschaftspraxis

Dr. med. Ansgar Rieke, Arzt für Innere Medizin / Nephrologie /

Infektiologie (DGI), Immunologische Ambulanz, II. Medizinische Klinik,

Klinikum Kemperhof, Koblenz

Dr. med. Bernd Buchholz, HIV-Ambulanz der Universitätsklinik Mannheim

Dr. med. Christoph Mayr, Arzt, Praxis MVZ Ärzteforum Seestrasse

Dr. med. Gundula Notheis, Oberärztin und Leiterin der Immundefekt-Ambulanz

Dr. von Haunerschen Kinderspital

Dr. med. Hans Jäger, Gemeinschaftspraxis München

Dr. med. Holger Flick, DTMPH, Arzt, Medizinische Klinik mit Schwerpunkt

Infektiologie und Pneumologie Charité Universitätsmedizin

Dr. med. Jan- Siedentopf, Infektionsambulanz, Klinik für

Geburtsmedizin, Campus Virchow-Klinikum, Charité – Universitätsklinikum

Dr. med. Jörg Gölz, Praxiszentrum Kaiserdamm Berlin

Dr. med. Katharina von Weizsäcker, Infektionsambulanz, Klinik für

Geburtsmedizin, Campus Virchow-Klinikum, Charité – Universitätsklinikum

Dr. Rainward Bastian, Director, German Institute for Medical Mission

(DIfÄM)

Olaf Hirschmann, MPH, Advisor HIV/AIDS in Development Policy, Brot für die

Welt, Diakonisches Werk der EKD

P.D. Dr. med. Keikawus Arastéh, Direktor der Klinik für Innere Medizin

Infektiologie / Gastroenterologie, Vivantes Auguste-Viktoria-Klinikum

Prof. Dr. med. Gerd Fätkenheuer, Klinik I für Innere Medizin, Klinische

Infektiologie Universitätsklinikum

Prof. Dr. med. Hartwig Klinker, Leiter des Schwerpunktes Infektiologie,

Medizinische Klinik und Poliklinik II Klinikum der Universität

Prof. Dr. med. Jürgen Lohmeyer, Infektiologie-Ambulanz

Universitätsklinikum, Gießen

Prof. Dr. med. Norbert Suttorp, Director, Charité-Universitätsmedizin

Berlin Department of, Infectious Diseases

Marwin Meier, Co-ordinator HIV and AIDS, World Vision Germany

GREECE

Chrisoula Botsi, MD, ''s Sigros'' Hospital

Hadjichristodoulou Christos,MD,PhD, Ass.Professor of Epidemiology and

Infectious Diseases, Medical School of Larissa, University of Larissa

s Vasiloyiannakopoulos ,MD,PhD, Head of 1st Infectious Diseases

Department, ''Erricos Dunant'' Hospital, Vice President of the Hellenic

Association of Tropical,Geographical and Travelling Medicine

Sophia Kourkoudi, MD, Internal Medicine, Infectious Diseases Department,

“s Sigros†Hospital, Athens

Kirsten Loio, MD, Internal Medicine, Infectious Diseases Department,

“s Sigros†Hospital, Athens

s Grilias, MD

Hellenic Association for Protection of People with Hemophilia

Gatsiou Hariklea ,MD, Internal Medicine, ''Erricos Dunant'' Hospital

Koutsouri Natassa,MD, Internal Medicine, ''Erricos Dunant'' Hospital

Kirpoglou Panagiotis,MD, Internal Medicine, ''Erricos Dunant'' Hospital

Amanatidou Konstantina,MD, Internal Medicine, ''Erricos Dunant'' Hospital

Rapti Rena ,MD, Internal Medicine, ''Erricos Dunant'' Hospital

Dimou Evangelini,MD, Internal Medicine, ''Erricos Dunant'' Hospital

Kanelopoulos Petros,MD,PhD, Internal Medicine, ''Erricos Dunant'' Hospital

Vassilopoulou Adamantia,MD, Internal Medicine, ''Erricos Dunant'' Hospital

Palamarou ,MD, Internal Medicine, ''Erricos Dunant'' Hospital

Sevastianos Vassilios,MD, Internal Medicine, ''Erricos Dunant'' Hospital

Peros Ioannis, MD,PhD, Dermatologist, ''Erricos Dunant'' Hospital

Hellenic Association of Tropical,Geographical and Travelling Medicine

ACT UP Hellas

Greek Committee of Feeding Minds,Fighting Hunger

Igisipolis,Club for Dialogue and Activism

Hellenic Branch of Feminist net

Antigoni: European Watch Against Racism and Xenophobia

Helen Choremi-Papadopoulou, MD, Ass. Professor of Athens University,

Director of the Immunology-

Compatibility Department, General Hospital “Laikoâ€

HONG KONG

Dr. Kath Reynolds, BMedSci, MBBS, FRACGP, MPH, Trop Med, Central Hong Kong

ICELAND

Albert Adalsteinsson, HIV+ Group Iceland

ITALY

Italian League for Fighting AIDS (LILA)

Action Aid International

Amref Italia

Lila Cedius onlus

Acra iamo lo Sviluppo

Ricerca e azione

Osservatorio Italiano sull'Azione Globale contro l'AIDS

Professor Fredy Suter, Primario U.O. Malattie Infettive, OO.RR. Bergamo

Siniscalchi, Dipartimento di Medicina Clinica e Sperimentale, Sezione

di Farmacologia, Università di Ferrara

e Dionisio, Coordinatore “Access to drugs: International Policiesâ€

CLIA, Italia e Direttore della Divisione di Malattie Infettive

dell’Ospedale di Pistoia

Emanuele Nicastri, Dipartimento di Epidemiologia, Istituto Nazionale

Malattie Infettive Lazzaro Spallanzani

Mauro Moroni, Università di Milano, Luigi Sacco – Milano

Danise, Infectious Diseases, Milano

Maurizio Bonati, Istituto Negri

Gianni Tognoni, Istituto Negri

Silvio Garattini, Presidente, Istituto Negri

Alberto Castagnola, Economista, Presidente Formin

Giovanna Melandri, Parlamentare, Commissione Affari Esteri, Camera dei

Deputati

Walter Veltroni, Sindaco di Roma

Luciano Vecchi, Parlamentare

Vittorio Agnoletto, Europarlamentare, Gruppo GUE, Sinistra Unitaria Europea

Francesco Martone, Parlamentare, Commissione Affari Esteri e Migrazione

Senato della Repubblica

Luigi Malabarba, Parlamentare, Senato della Repubblica

Donati, Parlamentare, Senato della Repubblica

Tommaso Sodano, Parlamentare, Senato della Repubblica

Alberto Michelini, Parlamentare, Esperto per il Piano di Azione G8 per

l’Africa

a tini, Europarlamentare, Presidente Commissione Sviluppo

Umberto Guidoni, Europarlamentare, Gruppo GUE, Sinistra Unitaria Europea

Dott. Caterina Uberti-Foppa, MD, Infectious Diseases Clinic, HSR Milano

Dr. Massimo Cernuschi, Medico Infettivologo, Centro San Luigi di Milano,

Presidente, Associazione Solidarietà AIDS, Milano

o Lazzarin, Director, Clinic of Infectious Diseases of San Raffaele

Scientific Institute

Alessandro Soria, Clinic of Infectious Diseases, Vita-Salute Univeristy,

San Raffaele Scientific Institute

Elena Seminari, MD, San Raffaele Scientific Institute

Giovanna Travi, MD, Department of Infectious Disease, San Raffaele

Institute

Dr.sa Ratti Deborah, MD, Department of Infectious Disease, San Raffaele

Hospital

IRAN

Persia+

ISRAEL

Gideaon Hirsh, MD, Executive Director, Israel AIDS Task Force

JAPAN

Naomi Wakasugi MD., PhD., Professor, Graduate School of Political Science,

WASEDA University Takashi Sawada, MD, Vice Chair Person, Services for the

Health in Asian African Regions (SHARE)

LATVIA

Aleksandrs Molokovskis, Board Chair, Association HIV. LV

AGIHAS (PLWHA Support Group)

THE NETHERLANDS

Marcel van Soest, Executive Director, World AIDS Campaign

Sjoera Dikkers,Director, Stop AIDS Now!

Mauro Guarinieri, Global Network of People living with HIV/AIDS (GNP+)

Heintze, Director, The Evert Vermeer Stichting

NICARAGUA

Asociación Nicaraguense de Personas Vivendo con VIH y SIDA

NORWAY

Dr. Andy Oxman, Senior Research, Norwegian Knowledge Center for the Health

Services

Dr. -Arne Røttingen MD PhD MSc, Director General, Norwegian Knowledge

Center for the Health Services

Berit Mørland, DDS, PhD, Deputy Director, Norwegian Knowledge Center for

the Health Services

President, HTA-International

Johan Bruun MD PhD, Professor, Senior Consultant Infectious Diseases,

Ulleval University Hospital

Oystein Anders Strand MD PhD, Senior Consultant, Infectious Diseases,

Akershus University Hospital

PERU

Asociación Lazos de Vida

SOUTH AFRICA

Sipho Mthathi, General Secretary, Treatment Action Campaign

Prof. Andy Gray, Centre for the AIDS Programme of Research in South Africa

(CAPRISA)

Dr , Department of Medicine, Edendale Hospital, University of

KwaZuluNatal

Dr Boulle, Infectious Diseases Epidemiology unit, University of Cape

Town

Dr Elma de Vries, Rural Doctors Association of South Africa (RuDASA)

Artists for a New South Africa

SPAIN

Gatell MD, Infectious Diseases and HIV Unit, Hospital Clinic

Barcelona, Vice President European HIV Society

Elena Valenciano, Member of the EU Parliament

Francisca Pleguezuelos, Member of the EU Parliament

Angel Martínez, Member of the EU Parliament

Carles Campuzano I Canades, Member of EU Parliament

Espinosa, Red Cross

Acquet, Service Comptabilité, Bayer Crop Science SA Lyon

Tenemos SIDA

GobalSIDA

A+MAS

Anesvad

Acción contra el SIDA

IAVI

Fundación Ecología y desarrollo

Fundación Triángulo

Más+Madrid

RED 2002

Save the Children

World Aids Campaign

Farmamundi

SWEDEN

Per Björkman, M.D. Ph.D, Dept. Of Infectious Diseases, Malmoe University

Hospital

Sandström MD, PhD, Professor, Department of Infectious Diseases,

Karolinska University Hospital

Sven Britton, Professor, Center for Infectious Medicine, Department of

Medicine, Karolinska Institutet

SWITZERLAND

Bernard Hirschel, Division des Maladies Infectieuses, Unité VIH/SIDA

Hôpital Universitaire de Genève

andra Calmy, MD, Research Fellow, Geneva University Hospital

n Reinhard, Déclaration de Berne

Sepp Gähwiler, CEO, Bethlehem Mission Immensee

Gerhard Bärtschi , CEO, TearFund Switzerland

s Loebell, Terre des Hommes

Pharmaciens Sans Frontières

Ecumenical Advocacy Alliance

THAILAND

Praphan Phanuphak MD, Professor of Medicine, Department of Medicine,

Faculty of Medicine, Chulalongkorn University; and Director of HIV

Netherlands Australia Thailand, Thai Red Cross AIDS Research Centre

Kiat Ruxrungtham, M.D., Associate Professor of Medicine, Head, Division of

Allergy and Clinical Immunology, Department of Medicine, Faculty of

Medicine, Chulalongkorn University; and Deputy Director of HIV Netherlands

Australia Thailand, Thai Red Cross AIDS Research Centre

Jintanat Ananworanich MD, Chief, South East Asia Research with Hawaii

(SEARCH) Consultant, The HIV Netherlands, Australia, Thailand Research

Collaboration (HIV-NAT)

Duncombe MD, Senior Staff Physician, The HIV Netherlands, Australia,

Thailand Research Collaboration (HIV-NAT)

Somsit Tansupsawadikul MD, Senior Physician, Bamrasnaradura Hospital

Kulkanya Chokephaibulkit MD, Senior Pediatrician, Department of

Paediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University

Nirun Vanprapar MD, Pediatrician, Department of Paediatrics, Faculty of

Medecine, Siriraj Hospital

Keswadee Lapphra MD, Pediatrician, Department of Paediatrics, Faculty of

Medecine, Siriraj Hospital

Ploenchan Chetchotisakd MD, Professor of Medicine, Department of Medicine,

Faculty of Medicine, Khon Kaen University

Pope Kosalaraksa, MD, Associate Professor of Paediatrics, Department of

Paediatrics, Faculty of Medicine, Khon Kaen University

Pranee Moungnoi MD, Consultant Psychiatrist, Department of Child and

Adolescent Psychiatry, Institute of Child Health

Manop Srisuphanthavorn MD, Chief Medical Officer, Bangkwang Central Prison

Witaya Petdachai MD, Hospital Deputy Director and Head of Paediatrics,

Phrachomklao Hospital

Chureeratna Bowonwatanauwong, MD, Senior Physician, Chonburi Regional

Hospital

Noppadon Sereerat MD, Director, Kuchinarai Royal Crown Prince Hospital,

Kuchinarai, Kalasin

Jon Ungphakorn, Senator and member of Public Health Committee, The Senate,

Parliament House

Sureerat Thimakkra, Representative, National Economic and Social Advisory

Council

Vithaya Kulsomboon PhD, MPHM, Chair of Social Pharmacy Department ,

Faculty of Pharmaceutical Sciences, Chulalongkorn University

Niyada Kiatying-Angsulee, Ph.D, Faculty of Pharmaceutical Sciences,

Chulalongkorn University

Jiraporn Limpananont, Faculty of Pharmaceutical Sciences, Chulalongkorn

University

Sumlee Jaidee, Asst. Professor, Faculty of Pharmaceutical Sciences,

Chulalongkorn University

Kamon Uppakaew, Chairman, Thai Network for People With HIV/AIDS

Nimit Tienudom, Director, AIDS Access Foundation

Paisan Suwannawong, Director, Thai AIDS Treatment Action Group (TTAG)

Karyn Kaplan, Director, Policy and Development, Thai AIDS Treatment Action

Group (TTAG)

UNITED KINGDOM

Christian Aid

International Planned Parenthood Federation

DHIVERSE

The UWESO (Uganda Women’s Effort to Save Orphans) UK Trust

National AIDS Trust

International HIV/AIDS Alliance

UK Coalition of People Living with HIV and AIDS

Dr. Ed Wilkins, Specialist in HIV/AIDS and WHO Consultant, North Manchester

Hospital

Fiona Pettitt, International Community of Women living with HIV/AIDS (ICW)

VENEZUELA

ACCSI - Acción Ciudadana Contra el SIDA